Skip to main content
. 2011 Oct 18;152(12):4974–4983. doi: 10.1210/en.2011-1182

Fig. 1.

Fig. 1.

Fetal ovarian genes (mRNA) that exhibit changes in expression between d 65 (white bars) and d 90 (black bars) of gestation as determined by quantitative RT-PCR of mRNA from whole ovarian tissue of control, T-treated, and T plus AR antagonist-treated (TF), female fetuses. Because no treatment effects were observed, the data for all treatment groups were pooled by age. Results are expressed as mean ± sem. Asterisks denotes an age effect (*, P < 0.05; **, P < 0.01).

HHS Vulnerability Disclosure